SoftBank Group Corp.’s plans to invest $100 billion in artificial intelligence infrastructure in the US have slowed, with ...

The ongoing discussions could transform OpenAI's setup, shifting it from its original nonprofit research focus to a mixed ...

The FDA has started exploring how AI can be used to accelerate drug approvals in collaboration with OpenAI amid oversight ...

Their latest public exchange unfolded on Saturday on X, sparked by a political flashpoint involving U.S. President Donald ...

The AI moved the cake (which had been barely visible behind the paper towel roll in the original still) to be the focal point ...

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

OpenAI, backed by Microsoft's $13 billion investment, is reportedly renegotiating its deal with the software giant. The aim ...

A reset of the contract, drafted when Microsoft invested an initial $1 billion in OpenAI six years ago, is crucial to a ...

OpenAI and Microsoft are locked in some intense negotiations that could decide the future of one of the world’s biggest ...

OpenAI, the maker of the popular artificial intelligence tool ChatGPT, is now working on new types of subscription plans.

OpenAI and Microsoft are rewriting the terms of their multibillion-dollar partnership in a high-stakes negotiation designed to allow the ChatGPT maker to launch a future IPO, while ...

Billionaire Sam Altman’s OpenAI and Microsoft are engaged in high-level negotiations to redefine the terms of their multibillion-dollar partnership, in ...